| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | China | 1 | |
| #6 | Israel | 1 | |
| #7 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Tsang Kwong Y | 9 |
| #2 | Arlen Myron | 7 |
| #3 | Stewart Thomas H M | 3 |
| #4 | Gershoni Jonathan | 3 |
| #5 | Fasick Jeffrey | 2 |
| #6 | Panayotatos Nikos | 2 |
| #7 | Stewart T H M | 1 |
| #8 | Gershont J | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2006004950A2 | Humanized monoclonal antibody 31.1 as an anticancer agent | |
| WO02074251A2 | Monoclonal antibody therapy for pancreas cancer | |
| WO0220617A1 | The identification and development of specific monoclonal antibodies to squamous cell carcinoma | |
| CA2328181A1 | Immunomodulatory compositions of mmtv antigens and methods of using same |